These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34636915)

  • 1. Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia.
    Pickles K; Scherer LD; Cvejic E; Hersch J; Barratt A; McCaffery KJ
    JAMA Netw Open; 2021 Oct; 4(10):e2128380. PubMed ID: 34636915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
    Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
    Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Associated with Informed Decisions and Participation in Bowel Cancer Screening among Adults with Lower Education and Literacy.
    Smith SK; Simpson JM; Trevena LJ; McCaffery KJ
    Med Decis Making; 2014 Aug; 34(6):756-72. PubMed ID: 24421292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing 3 techniques for eliciting patient values for decision making about prostate-specific antigen screening: a randomized controlled trial.
    Pignone MP; Howard K; Brenner AT; Crutchfield TM; Hawley ST; Lewis CL; Sheridan SL
    JAMA Intern Med; 2013 Mar; 173(5):362-8. PubMed ID: 23400279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
    Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
    Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supporting informed decision making for prostate specific antigen (PSA) testing on the web: an online randomized controlled trial.
    Evans R; Joseph-Williams N; Edwards A; Newcombe RG; Wright P; Kinnersley P; Griffiths J; Jones M; Williams J; Grol R; Elwyn G
    J Med Internet Res; 2010 Aug; 12(3):e27. PubMed ID: 20693148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of US and Australian men's values and preferences for PSA screening.
    Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
    BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? A randomised controlled trial.
    Gattellari M; Ward JE
    J Med Screen; 2003; 10(1):27-39. PubMed ID: 12790313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
    Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
    Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating two decision aids for Australian men supporting informed decisions about prostate cancer screening: A randomised controlled trial.
    Pickles K; Kazda L; Barratt A; McGeechan K; Hersch J; McCaffery K
    PLoS One; 2020; 15(1):e0227304. PubMed ID: 31940376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
    Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
    J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring patient perceptions of PSA screening for prostate cancer: risks, effectiveness, and importance.
    Smith SD; Birtwhistle R
    Can Fam Physician; 2012 Sep; 58(9):e502-7. PubMed ID: 22972741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
    Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
    Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A patient recall program to enhance decisions about prostate cancer screening: a feasibility study.
    Denberg TD; Bhide M; Soenksen A; Mizrahi T; Shields L; Lin CT
    BMC Fam Pract; 2009 Nov; 10():75. PubMed ID: 19948028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Fenton JJ; Weyrich MS; Durbin S; Liu Y; Bang H; Melnikow J
    JAMA; 2018 May; 319(18):1914-1931. PubMed ID: 29801018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.
    Pickles K; Carter SM; Rychetnik L
    BMJ Open; 2015 Mar; 5(3):e006367. PubMed ID: 25783420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
    Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
    Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.